It has a classic Israeli miracle.
Israeli biotech company Accelerated Evolution Biotechnologies (AEBi) announced a medical breakthrough to cure cancer.
Scientists in AEB say they have discovered a way of using peptides, amino acids, for targeting and killing cancer cells.
SEE ALSO:Why the diagnosis of TB can actually be lung cancer
"We believe we will offer a full cure for cancer in a year," AEB Chairman Dan Aridor of Jerusalem Post said.
Although the miracle drug was only tested on mice, Israelis are on the brink of developing a cancer drug for human beings.
Scientists in the company still have several years of testing before the drug is approved for human medicines.
AEB Chairman Dan Aridor said: "Our cancer treatment will be effective from the first day, it will last for several weeks and will have no or minimal side effects at much lower costs than most treatments on the market."
He continued, "Our solution will be both generic and personal."
SEE ALSO:More than 1,000 bleaching products on a black list
First reconnaissance experiments on mice led to promising results with an indication that inhibited the growth of human cancer cells and did not affect healthy cells in mice.
The next phase of the experiments will include clinical trials that could be completed over "several years" and, in specific cases, treatment would be available.
In Kenya, the Department of Health estimates that approximately 39,000 new cases of cancer are diagnosed each year.
Approximately 27,000 people die annually from this disease – the number three among the major murder diseases in the country.
The cheapest cancer treatment in Kenya is Sh500,000, but this value can go as high as millions of shillings when it comes to blood cancer.
SEE ALSO:A woman is a big fight to defeat AIDS and cancer
Accelerated evolution of BiotechnologiesCancerCancer cure